Patents/Assignees

Actelion Pharmaceuticals Ltd

9 patents in portfolio

US12485119utility2025
Methods of Treating Pulmonary Arterial Hypertension
0 cites
US12419887utility2025
Transitioning Patients Treated for Pulmonary Arterial Hypertension to Selexipag
0 cites
US12121516utility2024
Pharmaceutical Composition Comprising Selexipag
0 cites
US11771683utility2023
Dosing Regimen for a Selective S1P 1 Receptor Agonist
0 cites
US11723896utility2023
Pharmaceutical Combination Comprising Ponesimod
0 cites
US11672783utility2023
Pharmaceutical Combination Comprising a Selective S1P1 Receptor Agonist
0 cites
US11648249utility2023
Stable Pharmaceutical Compositions Comprising a Pyrimidine-sulfamide
0 cites
US11612600utility2023
Pharmaceutical Composition Comprising Macitentan for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
0 cites
USD0974921design2023
Pharmaceutical Package
0 cites